Skip to main content

Zerbaxa News

The previous label for the antibacterial drug Zerbaxa might be misinterpreted and lead to an overdose of the drug. The FDA has asked the manufacturer to label this drug more clearly, in order to prevent any problems.

Is Zerbaxa Safe?

Zerbaxa (a combination of both ceftolozane and tazobactam) is sometimes used to treat urinary tract infections (UTIs) or more complicated abdominal infections. The FDA, at this point, is not recommending any changes to how this drug is being used or removing it from the market, but hoping to clarify the label in order to make sure patients, like you, receive the proper dosage.

Zerbaxa Side-Effects

Thankfully, no one has reported any bad side-effects from overdosing with Zerbaxa to the FDA yet. The FDA might have caught this problem before anyone was harmed.

However, if someone you love was treated for a urinary or abdominal infection, and suffered or died under unusual circumstances, you might want to consult a lawyer. A good attorney can help review medical records to determine if they received Zerbaxa and someone’s mistake lead to their death.
Labels:

Popular posts from this blog

News About Phenobarbital Tablets by C.O.Truxton

Do you own a bottle of Phenobarbital Tablets by C.O. Truxton, Inc.?   Maybe you, or someone you know, has been prescribed phenobarbital tablets for sleep, or to control convulsions or seizures. C.O. Truxton, Inc., has recalled Phenobarbital Tablets, 15mg, because someone who bought a bottle of this medication discovered the label had been placed in error on a bottle of this medication with a different dosage strength. The bottle labeled 15mg tablets was actually 30mg tablets. This mistake on the label could potentially cause someone to accidentally take an overdose of phenobarbital. If you take an overdose of phenobarbital, it can cause: your heart to beat too fast  your breathing to be too rapid   you to become pale, weak, and sweat heavily   you to become unconscious   your kidneys to fail, leading to reduced urine, swelling of legs and feet, possibly confusion, shortness of breath  you to fall into a coma  you to need life-saving emergency treatment  Even though onl
Read more

Infant Sleep Positioners News

Parents and caregivers are advised to provide adequate comfort during sleep to babies. Sleep is essential for growth and development of a baby. Before birth, an infant spends a tremendous amount of time sleeping. That explains why after birth, babies sleep for long hours. Newborns sleep for approximately 18 hours a day waking up during a diaper change and to feed. In attempting to provide babies comfort when sleeping, some parents use infant sleep positioners. Most parents are unaware of sleeping positioners’ safety and adverse side effects. In this article, we provide an in-depth look at the safety and side effects of infant sleep positioners, anti-roll pillows and nests. Are Sleep Positioners Safe? Sleep positioners, also known as anti-roll or nests do more harm than good. They make babies struggle to breath leading to death. Suffocation is among the leading cause of infant deaths in the United States, accounting for approximately 4,000 mortalities annually according to the Nati
Read more

News About Codeine and Tramadol Restrictions for Children

Earlier this year, the Food and Drug Administration warned parents against giving their young ones prescription drugs with codeine and tramadol. The agency said that the drugs could lead to severe breathing problems among the children and even death. Codeine is indicated as a suitable drug for pain and cough while Tramadol heals pain. Codeine is also used as a cough syrup for toddlers and cold remedies. Manufactured by Par Pharmaceuticals, codeine is a generic medicine which is associated with various brands. It is usually marketed as a single ingredient drug or in combination preparations with paracetamol, aspirin, and ibuprofen.  The various combinations also pose a greater risk to children aged 12 years and below and among adolescents aged 18 years and below.  The drug is also marketed in products containing muscle relaxers. Healthcare providers are discouraged from prescribing the drug to adolescents aged between 12  and 18 years who are obese or show any other conditions that ma
Read more